Instead of enjoying my retirement and focusing on my health, I carry around the overwhelming burden of Imbruvica’s price.
As The Fight To Lower Drug Prices Ramps Up, Audrey Baker Will Lead P4AD’s Communications Efforts
Between the high cost of insulin and other supplies, affording the necessary treatments to survive as a diabetic can be incredibly costly.
New Report Debunks Pharma's Claim That Any Restraint On Its Unilateral Pricing Power Will Destroy Innovation And Access To New Medicines.
Can we constrain drug corporations’ unfettered pricing power in the United States and still get the innovation we seek?